Table 6.
Hormones and body composition before and after 2-months of well-balanced diet intervention
| Variable | Pre treatment | Post treatment | Δ (95 %) | P value |
|---|---|---|---|---|
| HOMA | 1.97 (1.44 to 2.62) | 1.74 (1.26 to 2.51) | −0.18 (−0.33 to 0.52) | 0.006 |
| CRP (mg/dL) | 0.19 (0.11 to 0.35) | 0.18 (0.09 to 0.31) | −0.04 (−0.06 to −0.01) | 0.004 |
| ApoA1 (g/L) | 117.7 ± 25.9 | 119.9 ± 28.3 | 2.19 (−4.83 to 9.20) | 0.54 |
| ApoB1 (g/L) | 79.4 ± 23.9 | 84.2 ± 21.7 | 4.87 (−0.36 to 10.10) | 0.068 |
| Total-Cholesterol (mg/dl) | 202.5 ± 37.3 | 199.5 ± 38.9 | −2.99 (−8.66 to 2.68) | 0.30 |
| HDL-Cholesterol (mg/dl) | 52.28 ± 13.51 | 49.89 ± 12.75 | −2.39 (−4.01 to 0.71) | 0.006 |
| LDL-Cholesterol (mg/dl) | 127.76 ± 65.60 | 126.57 ± 68.00 | −1.19 (6.30 to −3.92) | 0.64 |
| Triglycerides (mg/dl) | 112.32 ± 74.08 | 115.26 ± 120.24 | 2.94 (−18.33 to 24.2) | 0.78 |
| Glucose (mg/dl) | 90.45 ± 9.42 | 89.41 ± 9.96 | −1.03 (−2.99 to 0.92) | 0.29 |
| ABSI | 6.15 ± 0.43 | 6.04 ± 0.44 | −0.10 (−0.14 to −0.06) | <0.001 |
| AIP | 0.28 ± 0.28 | 0.29 ± 0.29 | 0.01 (−0.03 to 0.04) | 0.74 |
| Leptin (pg/mL) | 178.00 (97.00 to 311.20) | 142.20 (80.50 to 250.10) | −17.30 (−31.45 to −5.35) | 0.006 |
| Adiponectin (ng/mL) | 70.40 (50.60 to 101.70) | 63.60 (42.30 to 96.30) | −7.35 (−11.20 to −3.80) | 0.0001 |
| Leptin/Adiponectin | 1.94 (1.11 to 4.43) | 2.04 (1.21 to 4.43) | 85.00 (−0.26 to 0.25) | 0.97 |
| GLP-1 (pmol/L) | 1.2 ± 0.5 | 2.0 ± 0.6 | 0.74 (0.54 to 0.95) | <0.0001 |
| Ghrelin (pg/mL) | 331.45 (216.40 to 516.50) | 291.00 (188.30 to 449.60) | 28.20 (−74.55 to 2.10) | 0.030 |
| Free fat mass (kg) | 45.8 ± 9.8 | 45.7 ± 9.7 | −0.10 (−0.44 to 0.23) | 0.55 |
| Android fat (%) | 48.9 ± 6.1 | 47.3 ± 6.0 | −1.58 (−2.12 to −1.05) | <0.0001 |
| BMI (kg/m2) | 29.8 ± 3.0 | 28.9 ± 2.9 | 0.89 (0.66 to 1.12) | <0.0001 |
API atherogenic index of plasma, ABSI body shape index, CRP c-reactive protein, GLP-1 glucagon-like peptide-1, HOMA homeostatic model assessment. Values in bold, p <0.05